436 related articles for article (PubMed ID: 20708006)
41. Monitoring hepatitis E virus fecal shedding to optimize ribavirin treatment duration in chronically infected transplant patients.
Marion O; Lhomme S; Del Bello A; Abravanel F; Esposito L; Hébral AL; Lavayssière L; Cointault O; Ribes D; Izopet J; Kamar N
J Hepatol; 2019 Jan; 70(1):206-209. PubMed ID: 30563687
[No Abstract] [Full Text] [Related]
42. Chronic hepatitis E in a heart transplant patient: sofosbuvir and ribavirin regimen not fully effective.
Todesco E; Mazzola A; Akhavan S; Abravanel F; Poynard T; Roque-Afonso AM; Peytavin G; Marcelin AG; Calmus Y; Lecuyer L; Guillemain R; Conti F
Antivir Ther; 2018; 23(5):463-465. PubMed ID: 29504509
[TBL] [Abstract][Full Text] [Related]
43. Zinc Salts Block Hepatitis E Virus Replication by Inhibiting the Activity of Viral RNA-Dependent RNA Polymerase.
Kaushik N; Subramani C; Anang S; Muthumohan R; Shalimar ; Nayak B; Ranjith-Kumar CT; Surjit M
J Virol; 2017 Nov; 91(21):. PubMed ID: 28814517
[TBL] [Abstract][Full Text] [Related]
44. Pegylated interferon may be considered in chronic viral hepatitis E resistant to ribavirin in kidney transplant recipients.
Ollivier-Hourmand I; Lebedel L; Lecouf A; Allaire M; Nguyen TTN; Lier C; Dao T
BMC Infect Dis; 2020 Jul; 20(1):522. PubMed ID: 32677900
[TBL] [Abstract][Full Text] [Related]
45. Phylogenetic demonstration of hepatitis E infection transmitted by pork meat ingestion.
Riveiro-Barciela M; Mínguez B; Gironés R; Rodriguez-Frías F; Quer J; Buti M
J Clin Gastroenterol; 2015 Feb; 49(2):165-8. PubMed ID: 24637729
[TBL] [Abstract][Full Text] [Related]
46. Treatment of chronic hepatitis E in a patient with HIV infection.
Dalton HR; Keane FE; Bendall R; Mathew J; Ijaz S
Ann Intern Med; 2011 Oct; 155(7):479-80. PubMed ID: 21969351
[TBL] [Abstract][Full Text] [Related]
47. Successful treatment of hepatitis E virus-associated cryoglobulinemic membranoproliferative glomerulonephritis with ribavirin.
Del Bello A; Guilbeau-Frugier C; Josse AG; Rostaing L; Izopet J; Kamar N
Transpl Infect Dis; 2015 Apr; 17(2):279-83. PubMed ID: 25708383
[TBL] [Abstract][Full Text] [Related]
48. Treatment of Hepatitis E.
Hui W; Wei L; Li Z; Guo X
Adv Exp Med Biol; 2016; 948():211-221. PubMed ID: 27738987
[TBL] [Abstract][Full Text] [Related]
49. Failure to respond to ribavirin despite elevated intra-erythrocyte zinc level in transplant-patients with chronic hepatitis E virus infection.
Marion O; Abravanel F; Izopet J; Kamar N
Transpl Infect Dis; 2019 Apr; 21(2):e13050. PubMed ID: 30663838
[No Abstract] [Full Text] [Related]
50. Sofosbuvir shows antiviral activity in a patient with chronic hepatitis E virus infection.
van der Valk M; Zaaijer HL; Kater AP; Schinkel J
J Hepatol; 2017 Jan; 66(1):242-243. PubMed ID: 27702641
[No Abstract] [Full Text] [Related]
51. Chronic hepatitis E after kidney transplantation with an antibody response suggestive of reinfection: a case report.
Panning M; Basho K; Fahrner A; Neumann-Haefelin C
BMC Infect Dis; 2019 Jul; 19(1):675. PubMed ID: 31362697
[TBL] [Abstract][Full Text] [Related]
52. The natural compound silvestrol inhibits hepatitis E virus (HEV) replication in vitro and in vivo.
Todt D; Moeller N; Praditya D; Kinast V; Friesland M; Engelmann M; Verhoye L; Sayed IM; Behrendt P; Dao Thi VL; Meuleman P; Steinmann E
Antiviral Res; 2018 Sep; 157():151-158. PubMed ID: 30036559
[TBL] [Abstract][Full Text] [Related]
53. Ribavirin treatment of a patient with chronic hepatitis E. First case reported in Latin America.
Gruz F; Munné MS; González J; Lizarraga Villagran MA; Raffaele PP; Descalzi VI
Acta Gastroenterol Latinoam; 2016 Jun; 46(2):122-5. PubMed ID: 28704018
[TBL] [Abstract][Full Text] [Related]
54. Study of hepatitis E virus infection of genotype 1 and 3 in mice with humanised liver.
Sayed IM; Verhoye L; Cocquerel L; Abravanel F; Foquet L; Montpellier C; Debing Y; Farhoudi A; Wychowski C; Dubuisson J; Leroux-Roels G; Neyts J; Izopet J; Michiels T; Meuleman P
Gut; 2017 May; 66(5):920-929. PubMed ID: 27006186
[TBL] [Abstract][Full Text] [Related]
55. Hepatitis E: latest developments in knowledge.
Pérez-Gracia MT; Suay-García B; García M; Mateos-Lindemann ML
Future Microbiol; 2016 Jun; 11():789-808. PubMed ID: 27203841
[TBL] [Abstract][Full Text] [Related]
56. Ribavirin Treatment Failure-Associated Mutation, Y1320H, in the RNA-Dependent RNA Polymerase of Genotype 3 Hepatitis E Virus (HEV) Enhances Virus Replication in a Rabbit HEV Infection Model.
Wang B; Mahsoub HM; Li W; Heffron CL; Tian D; Hassebroek AM; LeRoith T; Meng XJ
mBio; 2023 Apr; 14(2):e0337222. PubMed ID: 36809085
[TBL] [Abstract][Full Text] [Related]
57. In vivo evidence for ribavirin-induced mutagenesis of the hepatitis E virus genome.
Todt D; Gisa A; Radonic A; Nitsche A; Behrendt P; Suneetha PV; Pischke S; Bremer B; Brown RJ; Manns MP; Cornberg M; Bock CT; Steinmann E; Wedemeyer H
Gut; 2016 Oct; 65(10):1733-43. PubMed ID: 27222534
[TBL] [Abstract][Full Text] [Related]
58. Chronic hepatitis E in HIV patients: rapid progression to cirrhosis and response to oral ribavirin.
Neukam K; Barreiro P; Macías J; Avellón A; Cifuentes C; Martín-Carbonero L; Echevarría JM; Vargas J; Soriano V; Pineda JA
Clin Infect Dis; 2013 Aug; 57(3):465-8. PubMed ID: 23575198
[TBL] [Abstract][Full Text] [Related]
59. Requirement of the eukaryotic translation initiation factor 4F complex in hepatitis E virus replication.
Zhou X; Xu L; Wang Y; Wang W; Sprengers D; Metselaar HJ; Peppelenbosch MP; Pan Q
Antiviral Res; 2015 Dec; 124():11-9. PubMed ID: 26526587
[TBL] [Abstract][Full Text] [Related]
60. Chronic Hepatitis E Viral Infection After Liver Transplantation: A Regression of Fibrosis After Antiviral Therapy.
Mazzola A; Tran Minh M; Charlotte F; Hdiji A; Bernard D; Wendum D; Calmus Y; Conti F
Transplantation; 2017 Sep; 101(9):2083-2087. PubMed ID: 28376032
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
